Mora P T, Parrott C L, Baksi K, McFarland V
J Virol. 1986 Sep;59(3):628-34. doi: 10.1128/JVI.59.3.628-634.1986.
A clonal line of highly oncogenic spontaneously transformed mouse cells (104C) was transformed in tissue culture by simian virus 40 (SV40) and subsequently recloned (106CSC). This 106CSC cell line expressed T antigen and transplantation antigen but was about 100 times less tumorigenic than the 104C parent. When 10(5) 106CSC cells were injected into immunocompetent syngeneic mice, tumors were produced. From such tumors, cell lines were established in culture, all of which were consistently negative for T antigen. We found previously by solution DNA hybridization methods that the tumor cells were depleted in the early region of SV40 DNA which codes for the T antigen. We postulated that this loss occurs through a DNA rearrangement of unknown mechanism in one or a few 106CSC cells and that the tumors are then produced from such a cell or cells, whereas all the T-antigen-positive 106CSC cells are rejected by immunologic means. In this investigation we showed by the DNA transfer method using appropriately selected SV40 DNA probes that indeed the tumor cell clone (130CSCT) we selected to investigate came from one 106CSC cell in which the T-antigen-coding SV40 DNA sequences (but not all the early SV40 DNA sequences) were lost by an excision and recombination mechanism. We also showed that the 130CSCT cells, which are highly tumorigenic, could again be transformed by SV40 and that the resulting T-antigen-positive cloned derivative cells became much less tumorigenic (approximately 10(5)-fold), apparently again because of immunologic recognition and rejection. Indeed, when 10(7) T-antigen-positive cloned cells were injected, all the T-antigen-positive cells were rejected and the tumor was produced again from one or more T-antigen-negative cells. Thus, a one-step in vivo transplantation experiment allowed a selection (for tumorigenicity and against the SV40 T antigen) of a mutant mammalian cell with a DNA deletion at a definable site.
一种具有高度致癌性的自发转化小鼠细胞克隆系(104C)在组织培养中被猴病毒40(SV40)转化,随后进行了再克隆(106CSC)。这个106CSC细胞系表达T抗原和移植抗原,但其致瘤性比104C亲本低约100倍。当将10^5个106CSC细胞注射到具有免疫活性的同基因小鼠体内时,产生了肿瘤。从这些肿瘤中,在培养物中建立了细胞系,所有这些细胞系对T抗原始终呈阴性。我们先前通过溶液DNA杂交方法发现,肿瘤细胞中编码T抗原的SV40 DNA早期区域缺失。我们推测这种缺失是通过一种未知机制在一个或几个106CSC细胞中发生DNA重排而产生的,然后肿瘤由这样一个或几个细胞产生,而所有T抗原阳性的106CSC细胞则通过免疫方式被排斥。在本研究中,我们通过使用适当选择的SV40 DNA探针的DNA转移方法表明,我们选择用于研究的肿瘤细胞克隆(130CSCT)确实来自一个106CSC细胞,其中编码T抗原的SV40 DNA序列(但不是所有早期SV40 DNA序列)通过切除和重组机制丢失。我们还表明,具有高度致瘤性的130CSCT细胞可以再次被SV40转化,并且产生的T抗原阳性克隆衍生细胞的致瘤性大大降低(约10^5倍),显然又是因为免疫识别和排斥。实际上,当注射10^7个T抗原阳性克隆细胞时,所有T抗原阳性细胞都被排斥,肿瘤再次由一个或多个T抗原阴性细胞产生。因此,一步体内移植实验允许选择(针对致瘤性并对抗SV40 T抗原)在可定义位点具有DNA缺失的突变哺乳动物细胞。